Ardent Health Partners, LLC (ARDT) Earnings History
Annual and quarterly earnings data from 2016 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 82.7% | 6.8% | 3.5% |
| 2023 | 97.4% | 4.2% | 0.9% |
| 2022 | 81.4% | 4.2% | 3.7% |
| 2018 | 100.0% | 3.6% | -3.4% |
| 2017 | 100.0% | 4.1% | -1.2% |
Download Data
Export ARDT earnings history in CSV or JSON format
Free sign-in required to download data
Ardent Health Partners, LLC (ARDT) Earnings Overview
As of February 28, 2026, Ardent Health Partners, LLC (ARDT) reported trailing twelve-month net income of $205M, reflecting +3.5% year-over-year growth. The company earned $1.45 per diluted share over the past four quarters, with a net profit margin of 0.0%.
Looking at the long-term picture, ARDT's 5-year EPS compound annual growth rate (CAGR) stands at +73.7%, indicating exceptional earnings growth. The company achieved its highest annual net income of $210M in fiscal 2024, representing a new all-time high.
Ardent Health Partners, LLC maintains positive profitability with a gross margin of 0.8%, operating margin of 0.1%, and net margin of 0.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including HCA ($6.78B net income, 0.1% margin), THC ($1.41B net income, 0.1% margin), MPW (-$199M net income, -0.2% margin), ARDT has room to improve margins relative to the peer group. Compare ARDT vs HCA →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $210M | +318.2% | $406M | $1.58 | 3.5% | 6.8% |
| 2023 | $50M | -73.4% | $230M | $0.35 | 0.9% | 4.2% |
| 2022 | $189M | +232.1% | $217M | $1.32 | 3.7% | 4.2% |
| 2018 | -$143M | -301.2% | $150M | $-1.01 | -3.4% | 3.6% |
| 2017 | -$36M | -344.1% | $122M | $-0.25 | -1.2% | 4.1% |
| 2016 | $15M | - | $85M | $0.10 | 0.7% | 4.0% |
See ARDT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARDT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARDT vs AGIO
See how ARDT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARDT growing earnings?
ARDT EPS of $1.45 reflects slowing growth at +3.5%, below the 5-year CAGR of +73.7%. TTM net income is $205M. Expansion rate has moderated.
What are ARDT's profit margins?
Ardent Health Partners, LLC net margin is +0.0%, with operating margin at +0.1%. Below-average margins reflect competitive or cost pressures.
How consistent are ARDT's earnings?
ARDT earnings data spans 2016-2024. The current earnings trend is +3.5% YoY. Historical data enables comparison across business cycles.